1066867-42-2

Basic information

• Product Name: C₂₉H₄₀N₂O₈S
• CAS NO: 1066867-42-2
• Molecular Weight: 576.711
• Mol File: 1066867-42-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₂₉H₄₀N₂O₈S(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₉H₄₀N₂O₈S(1066867-42-2)
• EPA Substance Registry System: C₂₉H₄₀N₂O₈S(1066867-42-2)

Safety Data

• Hazardous Substances Data: 1066867-42-2(Hazardous Substances Data)

Upstream product

• 98760-08-8 (1-oxiranyl-2-phenylethyl)carbamic acid tert-butyl ester 
• 34985-37-0 (S)-2-methylbutylamine 
• 1026701-65-4 N-[(1S,2R)-2-hydroxy-3-[((2S)-2-methylbutyl)amino]-1-(phenylmethyl)propyl]-carbamic acid 1,1-dimethylethyl ester 
• 1026701-52-9 N-[(1S,2R)-2-hydroxy-3-[[(4-methoxyphenyl)sulfonyl][(2S)-2-methylbutyl]amino]-1-(phenylmethyl)propyl]-carbamic acid 1,1-dimethylethyl ester 
• 156928-09-5 (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol 

Relevant articles and documents

Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance

Summary The rapid evolution of HIV under selective drug pressure has led to multidrug resistant (MDR) strains that evade standard therapies. We designed highly potent HIV-1 protease inhibitors (PIs) using the substrate envelope model, which confines inhib